Plain-English translation of NCT05652478 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
Researchers are studying how certain HIV medications—specifically a class called integrase strand transfer inhibitors, including —affect how the body processes food and manages weight. Some people taking these medications gain weight without trying, but doctors don't fully understand why. This study will give healthy volunteers one of four different HIV medications for four weeks and carefully measure changes in their blood, tissues, and gut bacteria to figure out what's happening.
Doctors have noticed that this medication can cause unexpected weight gain in people taking it for HIV treatment, but they don't know the exact reason why. Understanding these effects in healthy volunteers could help develop better HIV treatments in the future that don't have this side effect.
You likely qualify if…
You likely don't qualify if…
You'll start with a screening visit, then have a two-week period where you don't take any study medication. After that, you'll take one of the four study medications every day for four weeks. During the study, you'll have multiple visits for blood draws, and you'll also have a small tissue sample taken from under your skin (a biopsy) and provide stool samples so researchers can examine changes in your metabolism and gut bacteria.
AI-generated summary from trial data · Sep 18, 2026 · Not medical advice
United States